Provided by Tiger Trade Technology Pte. Ltd.

Beyond Air, Inc.

0.7399
-0.0081-1.08%
Post-market: 0.77500.0351+4.74%17:43 EDT
Volume:96.76K
Turnover:72.69K
Market Cap:7.79M
PE:-0.15
High:0.7749
Open:0.7498
Low:0.7303
Close:0.7480
52wk High:6.39
52wk Low:0.6733
Shares:10.53M
Float Shares:9.16M
Volume Ratio:0.67
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0645
EPS(LYR):-13.7727
ROE:-240.21%
ROA:-51.20%
PB:0.96
PE(LYR):-0.05

Loading ...

Beyond Air-Tochter Beyond Cancer präsentiert Phase-1-Daten zu UNO-Therapie auf AACR 2026

Reuters
·
Feb 04

Beyond Air files to sell 7.86M shares of common stock for holders

TIPRANKS
·
Jan 31

XTL Biopharmaceuticals Moves to Acquire 85% Stake in NeuroNOS Ltd

Reuters
·
Jan 30

Beyond Air CEO to Present at Virtual Healthcare Investor Conferences

Reuters
·
Jan 28

Beyond Air Inc. to Announce Third Fiscal Quarter 2026 Financial Results via Conference Call and Webcast

Reuters
·
Jan 27

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 21

Beyond Air initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Jan 20

XTL Biopharmaceuticals Acquires 85% Stake in Beyond Air’s NeuroNOS Subsidiary

Reuters
·
Jan 15

Beyond Air Raises $5 Million in Private Placement of Common Stock and Warrants

Reuters
·
Jan 14

Press Release: Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dow Jones
·
Jan 14

Crude Oil Rises Sharply; US Inflation Rate Holds Steady At 2.7%

Benzinga
·
Jan 14

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR)

TIPRANKS
·
Jan 13

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire
·
Jan 13

XTL Biopharmaceuticals to Acquire NeuroNOS from Beyond Air

Reuters
·
Jan 13

X T L Biopharmaceuticals Ltd: Beyond Air to Receive up to $32.5 Mln in Upfront, Development and Commercial Milestone Payments

THOMSON REUTERS
·
Jan 13

X T L Biopharmaceuticals Ltd: Neuronos Will NOW Serve as Xtl's Flagship Platform for Autism and Neuro-Oncology Therapeutics

THOMSON REUTERS
·
Jan 13

Beyond Air Inc. Files Initial Beneficial Ownership Statement for CFO Daniel Moorhead

Reuters
·
Jan 07

Beyond Air Names Dan Moorhead Chief Financial Officer

Reuters
·
Dec 30, 2025

Beyond Air® Appoints Dan Moorhead as Chief Financial Officer

THOMSON REUTERS
·
Dec 30, 2025

Press Release: Beyond Air(R) Appoints Dan Moorhead as Chief Financial Officer

Dow Jones
·
Dec 30, 2025